Technological

Watch

Powered by:

OFFER AND DEMAND

NMBP-22-18 Osteoarticular tissues regeneration (RIA) : development and manufacturing of electrospun innovative devices.

ABSTRACT

A French SME provides contract R&D and manufacturing devices in the biomedical field and microtechnologies. Electrospinning allows the manufacturing of materials made of nano- and microfibers. Such materials can be used for regenerative medicine, drug delivery, filtration and coating metallic parts. The company is looking for partners to join a NMBP-22-2018 project where its electrospinning skills can be used to develop innovative medical materials. Coordinator and end-users are sought.

FULL DESCRIPTION

The company's expertise focuses mainly on class I and III medical devices, like long-term implants, active medical devices, advanced transluminal technologies and in vitro diagnostic devices. The devices, developed and manufactured by the company are in all medical fields, like cardiology, neurology, ophtalmology, urology and orthopaedics. Furthermore, the company is interested by developing electrospun materials for other fields.

The company, more than 35 years old, has been involved in the design, development, characterisation, manufacturing and pre-clinical investigations of medical devices made with electrospun materials. For such a purpose, it has invested in an industrial electrospinning systems which controls the temperature and humidity rate ensuring repeatability. Moreover, the system can be programmed for all day and night electrospinning. Ambitious projects can thus be realised.

The company has the know-how to electrospin bioresorbable and non-bioresorbable polymers and is always interested in electrospinning new polymers,. The company has developed electrospun patches loaded with drugs.

Furthermore, the company electrospins filters, patches, straight tubes and tubes with complex shapes. Metallic materials also can be coated by electrospinning. Characterisation of electrospun materials and devices (fiber diameter, thickness, mechanical properties, in vitro functionality evaluation, drug loading and release) is also possible.

The company can manufacture electrospun materials for pre- and clinical studies. These materials can be packaged in cleanroom prior to sterilisation.

For the call NMBP-22-2018, the company proposes these skills to develop innovative devices for osteoarticular tissues regeneration (RIA). For this call, the synthesis of the raw materials will be done by a Belgium partner and the design and processing by electrospinning will be done by the French company. Other possible partnerships are under study.

Partner expertise sought:

- Specific area of activity of the partner: Industrial partners are sought working mainly in the healthcare sector and willing to explore, test, design, manufacture new devices based on the electrospinning technology. The company has a strong interest in developing electrospun materials in all the following fields : cardiology, neurology, ophtalmology, urology and orthopaedics. New challenges in tissue regeneration and drug delivery systems would also be welcome.

Role/Task to be done : The partners they are looking for (coordinator and end-users), will be in charge of their workpackage. They will contribute to the good realisation of the project.

Cooperation in the Framework of Horizon 2020 will be strongly considered.

Advantages & innovations:

- Strong expertise, knowledge to design and manufacture medical devices and implants combined to an innovative technology and know-how leading to devices with new advanced properties,

- Successfully developed devices in a short time frame in the field of tissue engineering and drug delivery systems,

- All the innovation chain can be covered from design to packaging of the electrospun devices.

Development Stage:

Available for demonstration - The company has already developed electrospun devices for preclinical evaluation. It has investigated the electrospun of different materials. This expertise can be used for the development of the innovative device for osteoarticular tissues regeneration.

IPR:

Secret Know-how

Programme - Call:

Evaluation scheme: RIA Research and Innovation action 2 stageDeadline: 1st stage : 23 Janvier 20182nd stage Deadline: 28 June 2018

Website: http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/nmbp-22-2018.html

Deadline: 23/01/2018

Coordinator required: No

Sign-in or create an account

To express an interest in this profile, you must first sign in or create a new account.

If you already have an account, sign in here

Not got an account yet, sign up here

KEY INFORMATION Country of origin
FRANCE Profile date
12/12/2017 Deadline
14/01/2018 PARTNERSHIP(S) SOUGHT Research cooperation agreement

» Reference: RDFR20171122001

» More Information

« Go to Technological Watch

LATEST NEWS TECHNOLOGICAL WATCH

[23/04/2018] - Polymer Solutions acquires Phoenix Chemical

[23/04/2018] - Global Cerium Oxide Nanoparticles (Dispersion and Powder) Market 2018-2022 - Focus on Chemical Mechanical Planarization, Catalyst, Biomedical, Energy - ResearchAndMarkets.com

[23/04/2018] - CF Industries Holdings, Inc. Announces Dates for First Quarter 2018 Results and Conference Call

[23/04/2018] - Rehau closing window plant in Canada

This project has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n [310187].